Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A new wrinkle that will send all Patriot shareholders for the pink liquid.....

This highlights another item that troubles me greatly: why does this release, and the 10Q also, say that the rights were granted only by TPL? Should not PTSC also be mentioned as a grantor, as it is a 50% owner of the patents? I would otherwise not be concerned except that PTSC is specifically mentioned in the introductory sentence of this paragraph.

Unless I've missed it, this item has not yet been addressed/discussed? Thanks, and GLTAL

Share
New Message
Please login to post a reply